Characterization of a factor(s) from partially purified human gonadotrophin preparations which inhibit(s) the binding of radiolabelled human LH and human chorionic gonadotrophin to Candida albicans
- PMID: 1999672
- DOI: 10.1677/joe.0.1280139
Characterization of a factor(s) from partially purified human gonadotrophin preparations which inhibit(s) the binding of radiolabelled human LH and human chorionic gonadotrophin to Candida albicans
Abstract
We have shown previously that partially purified human chorionic gonadotrophin (hCG) preparations inhibited the specific binding of 125I-labelled hLH or hCG to Candida albicans membranes at much lower concentrations than did highly purified hLH or hCG preparations. We now describe the characterization and partial purification of a heat-labile glycoprotein from commercially available gonadotrophin preparations. The factor strongly inhibited LH binding to Candida membranes, but not to sheep or pig luteal LH receptors. This material had a molecular weight of 16,000-21,000 daltons, bound strongly to CM-Sepharose at physiological pH, and could be resolved completely from hCG and from epidermal growth factor-like factors present in commercial gonadotrophin preparations. Its activity was not attenuated by a range of inhibitors specific for the four major classes of proteolytic enzymes, nor did it inhibit hormone binding by causing degradation of 125I-labelled hLH or hCG tracers. Factors which inhibited hLH binding to Candida membranes were also present in partially purified human urinary and equine serum gonadotrophin preparations and in placental extracts, but were not detected in highly purified CG of hLH preparations. The properties of this factor were similar to those described for beta-core protein, a cleavage product of the beta subunit of hCG which is a contaminant of commercial gonadotrophin preparations. Highly purified beta-core protein inhibited 125I-labelled hLH binding to Candida membranes, but not to sheep luteal binding sites. Preparations of hCG depleted of inhibitor activity could stimulate adenylate cyclase activity in Candida membranes almost five fold. In contrast, partially purified inhibitor preparations strongly inhibited basal adenylate cyclase activity (to 18% of control levels). These observations suggest that endogenous LH-like factors, perhaps similar to beta-core proteins of hCG, may play a role in the regulation of morphogenesis in Candida species.
Similar articles
-
Binding sites for LH in Candida albicans: comparison with the mammalian corpus luteum LH receptor.J Endocrinol. 1991 Aug;130(2):177-90. doi: 10.1677/joe.0.1300177. J Endocrinol. 1991. PMID: 1919390
-
Specific binding sites for 125I-labelled human luteinizing hormone (hLH) in microsomal fractions from Drosophila.Mol Cell Endocrinol. 1990 Oct 22;73(2-3):93-104. doi: 10.1016/0303-7207(90)90122-o. Mol Cell Endocrinol. 1990. PMID: 2125284
-
Co-purification of a ribonuclease and human chorionic gonadotrophin beta-core protein from human urine and displacement of 125I-human luteinizing hormone from Candida albicans binding sites by ribonucleases.Mol Cell Endocrinol. 1997 Oct 31;134(1):69-76. doi: 10.1016/s0303-7207(97)00174-3. Mol Cell Endocrinol. 1997. PMID: 9406851
-
Thyrotropic action of human chorionic gonadotropin.Thyroid. 1995 Oct;5(5):425-34. doi: 10.1089/thy.1995.5.425. Thyroid. 1995. PMID: 8563483 Review.
-
Comparative use of urinary and recombinant human chorionic gonadotropins in women.Treat Endocrinol. 2004;3(6):371-9. doi: 10.2165/00024677-200403060-00005. Treat Endocrinol. 2004. PMID: 15511131 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources